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Abstract 21 
Objectives: Rodent models of major depressive disorder (MDD) are indispensable when 22 
screening for novel treatments, but assessing their translational relevance with human brain 23 
pathology has proved difficult. 24 
Methods: Using a novel systems approach, proteomics data obtained from post-mortem 25 
MDD anterior prefrontal cortex tissue (n =12) and matched controls (n = 23) were compared 26 
with equivalent data from three commonly used preclinical models exposed to environmental 27 
stressors (chronic mild stress, prenatal stress, social defeat). Functional pathophysiological 28 
features associated with depression-like behaviour were identified in these models through 29 
enrichment of protein-protein interaction networks. A cross-species comparison evaluated 30 
which model(s) represent human MDD pathology most closely.  31 
Results: Seven functional domains associated with MDD and represented across at least two 32 
models such as “carbohydrate metabolism and cellular respiration” were identified. Through 33 
statistical evaluation using kernel-based machine learning techniques, the social defeat model 34 
was found to represent MDD brain changes most closely for four of the seven domains.   35 
Conclusions: This is the first study to apply a method for directly evaluating the relevance of 36 
the molecular pathology of multiple animal models to human MDD on the functional level. 37 
The methodology and findings outlined here could help to overcome translational obstacles 38 
of preclinical psychiatric research.     39 
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1. Introduction 43 
Major depressive disorder (MDD) is the third leading cause of disability in the world and has 44 
been projected to become the number one cause of disability by 2030 (World Health 45 
Organization, 2004). However, current treatment options for this disorder remain limited with 46 
only one third of patients reaching remission following initial therapy (Trivedi et al., 2006). 47 
In order to develop novel and improved treatments, animal models of MDD are investigated 48 
to evaluate the potential benefits of promising new drug candidates. 49 
The aetiology of MDD is not well understood, the onset of the disorder is most likely 50 
precipitated by a combination of genetic and environmental factors. Depression-related 51 
behaviours have been reported in genetically modified rodent models (including 52 
manipulations of the serotonin transporter (Slc6a4), corticotrophin-releasing factor (Crh) and 53 
brain-derived neurotrophic factor (Bdnf)), following selective trait breeding, or after 54 
pharmacological challenges (corticosterone and lipopolysaccharide administration) or 55 
environmental stress exposure, as reviewed previously (Agid et al., 1999; Barkus, 2013; 56 
Berton et al., 2012; Cryan and Holmes, 2005; Markou et al., 2009; McArthur and Borsini, 57 
2006). Environmental stress is thought to be one of the most significant risk factors for the 58 
development of MDD, especially in an interaction with genetic risk factors, early life stress 59 
and ongoing stress may determine an individual’s vulnerability to develop depression 60 
(Charney and Manji 2004). Common environmental manipulations used in animal models of 61 
MDD include social defeat (SD), social isolation, chronic mild stress (CMS), learned 62 
helplessness, maternal deprivation and prenatal stress (PNS). However, these preclinical 63 
models are thought to have varying degrees of construct, face and predictive validity (Nestler 64 
and Hyman, 2010). 65 
Although no rodent model reflects a given psychiatric disorder in its complexity, they may 66 
represent certain neurocognitive or neurobehavioural endophenotypes, thus providing 67 
insights into certain aspects of the underlying molecular pathology associated with different 68 
symptom dimensions. Consequently, rodent models are most commonly used for preclinical 69 
drug evaluations due to the advantages of a homogenous breeding background and the 70 
potential for controlled experiments.  71 
In this study, we have attempted to develop and apply a novel methodology of evaluating and 72 
comparing the molecular changes associated with three widely used rodent models of MDD 73 
(based on different environmental stressors, i.e. SD, CMS, PNS), to human MDD post-74 
mortem brains. Proteomic data obtained from rodent models and human disease was 75 
evaluated using a network biology approach. Thus, it was possible to characterize and 76 
compare functional patterns associated with the molecular changes between species and 77 
models. 78 
2. Materials and Methods 79 
Detailed outlines of the statistical modelling, network filtering, GO term enrichment and 80 
kernel techniques used in this analysis are described in a previous study (Cox et al., 2016). 81 
Supplementary Figure 1 provides a step by step illustration of the methodology. 82 
        83 
2.1. Clinical and Preclinical Samples 84 
35 post-mortem anterior prefrontal cortex (Brodmann area 10 - BA10) brain samples were 85 
obtained from the Stanley Medical Research Institute (Torrey et al., 2000). Samples were 86 
derived from 12 MDD patients (with purely affective diagnoses and no psychotic features in 87 
their disease course) and 23 healthy control (CT) subjects. 88 
Tissue collection took place with the full informed consent of a first-degree relative to 89 
comply with the Declaration of Helsinki. As outlined previously (Gottschalk et al., 2014), 90 
there were no differences in grey and white matter volumes between samples, and no 91 
significant differences in brain side, gender or secondary axis diagnosis of alcohol 92 
abuse/dependency and drug abuse/dependency between patients and controls.    93 
Three stress-based rodent models of MDD commonly used in preclinical research were 94 
generated applying the standard protocols outlined below. Rats (Rattus norvegicus) were used 95 
in the CMS and PNS models and mice (Mus musculus) were used in the SD model. At the 96 
end of each protocol, rodents were sacrificed by decapitation, and frontal cortex tissue 97 
samples were collected from both stressed samples and a matching number of unstressed 98 
control samples. As in previous studies (Ma et al., 2009), the frontal cortex was defined as the 99 
anterior portion of the cortex up to 2.15 mm rostral from bregma.    100 
SD: 7-9 week old animals were exposed individually to 9-13 month old socially dominant 101 
aggressor animals for ten minutes each day, for ten successive days, in a 1:1 social 102 
dominance constellation as described previously (Berton et al., 2006; Krishnan et al., 2007). 103 
The two mice were kept in the same cage separated by a Plexiglas screen for the remaining 104 
24 hours for constant visual and olfactory cues, prolonging the defeat procedure. A different 105 
aggressor mouse was used each day to minimize inter-aggressor variability. On day eleven, 106 
all mice exposed to SD stress were subjected to the established social interaction test 107 
(Krishnan et al., 2007) which employs a video-tracking system to score interaction/avoidance 108 
behaviours towards an aggressor mouse. Following this test, all mice exposed to SD stress 109 
were sorted into either susceptible or resilient groups, by comparing the interaction test score 110 
ratio for each animal to established behavioural scores associated with defeat and resilience 111 
(Berton et al., 2006; Krishnan et al., 2007). An interaction test score ratio of 1, in which SD 112 
animals have displayed an identical amount of interaction with a social and a non-social 113 
target in the presence of a formerly unknown mouse, has been previously defined as the 114 
threshold for dividing defeated mice into susceptible and resilient groups. Twelve animals 115 
deemed susceptible in accordance to the SD procedure (social interaction score <1) described 116 
above, and 12 control animals which did not undergo defeat were sacrificed 24 hours after the 117 
final social interaction testing and 48 hours after the last defeat (SD mice only).  118 
CMS: 24 adult male rats were housed individually with free access to food and water. 12 119 
animals were maintained as controls and 12 animals were exposed to a mild stress regimen 120 
for three consecutive weeks, five days a week, based on a previously described CMS 121 
procedure (Moreau et al., 1992; Willner et al., 1987). Stressors consisted of repeated periods 122 
of confinement to small cages (24 × 10 x 9 cm), two periods of continuous overnight light 123 
exposure, one 18 hour period of food and water deprivation followed by 2 hours of restricted 124 
food access, one 18 hour period of water deprivation immediately followed by 1 hour’s 125 
exposure to an empty bottle, and one 18 hour period of group housing in a soiled cage. The 126 
CMS protocol was evaluated through three commonly used behavioural tests. The sucrose 127 
preference test (SPT) (Pothion et al., 2004) saw each animal given free access to 150ml of 128 
sucrose solution and 150ml of water. The SPT tests for reduced responsiveness to positive 129 
stimuli, which is symptomatic of depression in humans. The forced swim test (FST) (Herrera-130 
Ruiz et al., 2006) was then used to analyse whether animals showed inclinations towards 131 
despair by placing them in a situation where they may perceive that escape from the water is 132 
impossible (Borsini and Meli, 1988). Finally the tail suspension test (Pollak et al., 2010) was 133 
used as an additional quantifier of behavioural despair. Animals from the stress group 134 
displayed similar depression-related phenotypes in comparison to the control group as 135 
expected from previous work (Yang et al., 2014). All animals were sacrificed via decapitation 136 
following the end of the protocol. 137 
PNS: Pregnant dams were obtained at gestation day 6-7 and randomly assigned to control or 138 
prenatal stress groups after one week of acclimatisation. The stress groups were exposed to 139 
varying stressors during their third trimester, from gestational day 14 until day 20, following 140 
an established protocol (Sickmann et al., 2015). A different stressor was applied for each of 141 
these days. Following birth, all dams and pups were housed in a single cage and left 142 
undisturbed for 20 days. On postnatal day 21, pups were separated from their mothers and 143 
kept single housed. In an evaluation of the PNS paradigm, young adult animals were 144 
subjected to stress evaluation behavioural tests between postnatal days 50-70 (Sickmann et 145 
al., 2015). Locomotor and rearing/climbing activity was assessed over a 24h period as 146 
changes in circadian activity patterns can be symptomatic of depression-like behaviour. The 147 
FST was used as in the CMS procedure. Similar to previous work (Sickmann et al., 2015), 148 
animals from the stress groups displayed a phenotype related to increased behavioural despair 149 
and decreased exploratory behaviour. Adult male offspring (10 from the control group and 10 150 
from the stress group) were sacrificed at postnatal day 150. 151 
2.2. Label-Free LC-MS
E
 Analysis of Brain Tissue 152 
MDD tissue storage, preparation and proteomic abundance comparisons were performed as 153 
previously defined (Gottschalk et al., 2014). Approximately 12-16mg of mouse tissue per 154 
sample were used for the SD model and 22-28mg of rat tissue per sample were used for the 155 
CMS and PNS models. A previously published protein tissue isolation protocol was applied 156 
to all rodent model tissue samples (Ernst et al., 2012). Samples were added to a fractionation 157 
buffer containing 7M urea, 2M thiourea, 4% CHAPS, 2% ASB14 and 70 mM DTT at a 5:1 158 
(v/w) ratio (Martins-de-Souza et al., 2007). Sonification and vortexing (at 4°C for 30 min) of 159 
the samples was carried out before centrifuging at 17,000g at 4°C. A Bradford assay (Bio-160 
Rad) was used to determine protein concentrations of the 161 
supernatants in triplicate, using acetone to precipitate proteins (approximately 100 μg) from 162 
each sample. 100 μL of ammonium bicarbonate (50 mM) was used to dissolve the 163 
precipitates, before protein concentrations were determined. Reduction of protein sulfhydryl 164 
groups was carried out using 40 μg of proteins and 5 mM DTT at 60 °C for 30 min. 165 
Alkylation was carried out using 10 mM iodoacetamide and incubating in the dark at 37 °C 166 
for 30 min. Protein digestion was performed using porcine tosyl phenylalanyl chloromethyl 167 
ketone (TPCK)-treated trypsin at a 1:50 (w/v) ratio for 17 h at 37 °C. Reactions were stopped 168 
via the addition of 8.8 M HCl at a 1:60 (w/w) ratio.  169 
All tissue samples were analysed individually in technical duplicates using label-free liquid 170 
chromatography-coupled tandem mass spectrometry (LC-MS
E
). For the subsequent analysis, 171 
the Swiss-Prot human reference proteome (Uniprot release, Sep 2014; 20 209 entries) was 172 
used for peptide/protein identification. The protein sequences of the Mus musculus and Rattus 173 
norvegicus UniProt reference proteome files were merged to create a joint database (retrieved 174 
Sep 2014; total joint number of entries 24 577). LC-MS
E
 raw data were processed using the 175 
ProteinLynx Global Server v.2.5. (Waters Corporation), and Rosetta Elucidator v.3.3 (Rosetta 176 
Biosoftware), applying settings and procedures as reported previously (Gottschalk et al., 177 
2014). Following the export of all peptide signal intensities for each sample, pre-processing 178 
and statistical analysis was performed in R (R Development Core Team, 2013). Non-unique 179 
peptides were excluded. To avoid unspecific trypsin cleavage, only peptides with an amino 180 
acid sequence ending in R or K were considered. The first two principal components were 181 
used to identify sample outliers (Beniger et al., 1980) resulting in the removal of two CT 182 
samples and one MDD sample, one stress sample from the PNS model and one stress sample 183 
from the SD model. Log2 transformation was applied to stabilize data variance.  184 
Protein abundance changes for the human and rodent model comparisons (MDD compared to 185 
CT, or stress versus non-stressed controls in the rodents, respectively) were determined using 186 
a fixed effects linear model. This model adjusted for covariates in the post-mortem brain 187 
samples regarding age, gender, diagnoses of alcohol or substance abuse, brain pH, brain side 188 
and post-mortem interval (PMI). For the human tissue, the false discovery rate (FDR) was 189 
controlled by adjusting p-values according to the Benjamini Hochberg procedure (Benjamini 190 
and Hochberg, 1995) with a cut-off of 0.05. For each rodent model, the small sample sizes 191 
were accounted for by determining the real p-values for each protein through a permutation 192 
testing procedure as described previously (Cox et al., 2016).  193 
2.3. Protein-Protein Interaction Networks 194 
Protein-protein interaction (PPI) networks were created for MDD and the SD, CMS, and PNS 195 
rodent models using the software package Cytoscape v3.2.1 (Cline et al., 2007), enabling the 196 
comparison of MDD and rodent tissue on a functional level, based on the annotation of Gene 197 
Ontology (GO) terms to the detected significant protein abundance changes described above. 198 
The databases MINT (Zanzoni et al., 2002), IntAct (Hermjakob et al., 2004) and UniProt 199 
(Apweiler et al., 2004) were used to retrieve all available known PPI between the significant 200 
(corrected p-value ≤  0.05) protein abundance changes and their respective first-order protein 201 
interactors. Network nodes were filtered by taxonomy identifiers (9606 for Homo sapiens in 202 
the MDD network along with 10116 and 10090 for Rattus norvegicus and Mus musculus 203 
respectively in the rodent networks) while edges were filtered so that all connections other 204 
than direct interactions or physical associations between proteins were excluded. The 205 
structures of each network were characterized using three properties of complex networks: 206 
average degree which reflects connectivity, characteristic path length and density.  207 
2.3.1. GO term enrichment  208 
The ClueGO (Bindea et al., 2009) Cytoscape package was used to compute GO term 209 
enrichment on each PPI network. Settings and filtering methods were applied as described 210 
previously (Cox et al., 2016). The statistical significance of each GO term was computed 211 
using a two-sided hypergeometric distribution, determining whether GO terms occur at a 212 
frequency greater than would be expected by each term. The significance of each term was 213 
adjusted for FDR using the Benjamini Hochberg correction with a cut-off of 0.05. 214 
2.3.2. Kappa Score Grouping 215 
Functional grouping was applied to the list of terms for each network using the kappa score 216 
(Huang et al., 2007), a metric which reflects the degree of the relationship between GO terms, 217 
based on shared underlying proteins. A kappa score of 0.5 was used, as this requires a 218 
relatively large number of shared proteins in order for terms to be grouped (Bindea et al., 219 
2009; Merico et al., 2010), ensuring that each group has a distinct biological functionality. 220 
SD, CMS or PNS functional groups which did not contain at least two GO terms were 221 
excluded from the analysis. A more stringent threshold was applied to the MDD functional 222 
groups, as the MDD PPI network was a factor of ten larger than the rodent networks. This 223 
size discrepancy derives from the information bias in GO annotations and protein databases 224 
between human and rodent proteins. MDD functional groups which did not contain at least 225 
ten GO terms were excluded from the analysis. Groups were named according to the most 226 
significant GO term following the Benjamini Hochberg FDR correction mentioned in 2.3.1. 227 
2.3.3 Local Linear Embedding Kernel Group Augmentation 228 
A diffusion-type manifold embedding technique called a Local Linear Embedding (LLE) 229 
kernel was applied to enhance the biological interpretation and comparability of each 230 
functional group by augmenting them with closely related GO terms as previously outlined 231 
(Cox et al., 2016). Manifold embedding techniques classify data points in particular 232 
categories and are commonly used in bioinformatics. The kernel we apply here computes 233 
similarity scores based on a geometric interpretation of manifold embedding interpreting 234 
every GO term as a point on a virtual two-dimensional GO tree. The LLE kernel was selected 235 
because it emphasizes short-range interactions between GO terms (Roweis and Saul, 2000) 236 
and thus is typically used to group related proteins or genes (Lerman and Shakhnovich, 2007; 237 
Li et al., 2010; Zare et al., 2011). Every given GO term in a functional group was analysed 238 
for positive similarity values to other GO terms due to relative closeness on the GO tree. The 239 
LLE kernel group augmentation is based on the concept that the functional annotations added 240 
by this approach are highly likely to be related to biological functions already conveyed by 241 
that group (and closely related to the underlying PPIs). Therefore, this procedure results in 242 
more informative function groups of highly interconnected GO terms. 243 
2.4. Functional Comparison between MDD and Rodent Models 244 
Following augmentation, the percentage overlap of GO terms was computed between MDD 245 
functional groups and those of the three rodent models, using a Z score transformation. 246 
Related clusters of functional groups between MDD and each model were identified using 247 
hierarchical clustering with the Ward’s criterion metric. This enabled different functional 248 
domains of the disease which are represented across all three models, to be determined, 249 
where each domain consists of a vector of GO terms. 250 
2.4.1 Identification of Unique Functional Domains 251 
These functional domains were displayed by projecting the augmented MDD and rodent 252 
model groups into Cytoscape, creating four separate graphs of GO terms, in which nodes 253 
represent terms and edges connect the terms found to be related by the LLE kernel (see 254 
“Local Linear Embedding Kernel Group Augmentation”).  This projection enabled the 255 
identification of a subset of GO terms behind each domain which are completely unique to 256 
that domain, thus defining the biological functionality more precisely.  257 
2.4.2 Domain Comparison Using GO Term Similarity 258 
For each unique functional domain of human MDD represented across the three rodent 259 
models, a numerical quantification was obtained for which model represented the human 260 
domain most closely, by adapting an existing approach used in genetic research (Fröhlich et 261 
al., 2006; Speer et al., 2005). A similarity score was computed between rodent and human 262 
domains by first evaluating the pairwise similarity scores between individual GO terms in the 263 
domain vectors using the LLE kernel, and then obtaining the average of the best matching 264 
GO term similarity between the domains. The rodent and human domains are more similar, 265 
the closer the similarity scores are to 1.  266 
3. Results 267 
3.1. Protein Abundance Changes for Brain Tissue Comparisons 268 
1280 unique quantifiable proteins were identified across all post-mortem brain samples. 875 269 
were identified across all SD samples, 749 across all CMS samples and 887 across all PNS 270 
samples. Applying linear modelling followed by false discovery correction, found that 109 271 
proteins were differentially expressed in MDD patients compared to CT individuals. Linear 272 
modelling of the rodent models followed by permutation testing found 68 proteins to be 273 
differentially expressed in stressed compared to CT mice in the SD model, 43 in the CMS 274 
model and 30 in the PNS model.  (Supplementary Tables 1-4 display these proteins and their 275 
fold changes).  276 
3.2. PPI Networks and GO Term Enrichment Analysis   277 
By retrieving all available interactions from the protein databases UniProt, MINT and IntAct, 278 
PPI networks were created for MDD and all three rodent models from the significant proteins 279 
identified above and their respective first-order interactors. In order to characterize each of 280 
these networks, several commonly used structural properties of complex networks were 281 
computed, average degree, characteristic path length and density (Table 1).   282 
The CMS and PNS networks displayed a slightly greater connectivity and density, potentially 283 
because they are more compact as indicated by their smaller characteristic path length. 284 
Following functional enrichment analysis of the networks, and Kappa score grouping of the 285 
resulting terms, 77 MDD functional groups, 52 CMS groups, 41 SD groups and 9 PNS 286 
groups were obtained. Each group corresponds to a specific biological process. Table 2 287 
displays the top 5 groups for MDD and each rodent model, in order of significance.   288 
3.3. Identification of Corresponding Functional Domains Between MDD and Rodent 289 
Models 290 
Kernel techniques were used to enhance the identified functional groups, as described in the 291 
methods section. Subsequently the percentage overlap was computed between MDD and 292 
rodent model groups. It was found that groups which clustered together and overlapped are 293 
involved in closely related biological processes, resulting in the identification of seven 294 
functional domains of MDD in the post-mortem brains – “transport, localization and cellular 295 
import/export”, “development/differentiation and immune system”, “cytoskeleton and 296 
DNA/RNA processes”, “carbohydrate metabolism and cellular respiration”, “nucleic acid 297 
metabolism and ATP/GTPase activity”, “intracellular signalling/regulation & post-298 
translational modification” and “cellular response and receptor signalling”, which are also 299 
represented by the GO terms based on protein changes detected in the rodent models. The 300 
CMS model represented all seven of these domains and the SD and PNS models represented 301 
five, respectively. The domains are shown in Figure 1. Prior to quantifying which model was 302 
most representative of MDD for each functional domain, the individual groups of GO terms 303 
behind the seven domains for MDD and all three models were projected into Cytoscape. The 304 
resulting networks of GO terms (Figure 2) enabled the identification of a vector of terms 305 
which are unique to a certain domain, for both MDD and each of the three preclinical models.   306 
3.4. Quantification of Most Representative Rodent Model via GO Term Similarity 307 
Methods  308 
The vectors of GO terms for each domain were compared by computing scores based on GO 309 
term similarity, enabling the quantification of the model that represented MDD most closely 310 
(Table 3).   311 
The scores indicated that overall the SD model represented MDD most closely (to a greater 312 
extent than the other two models) for the functional domains “transport, localization & 313 
cellular import/export”, “cytoskeleton & DNA/RNA processes”, “intracellular 314 
signalling/regulation & post-translational modification” and “cellular response & receptor 315 
signalling”. The SD and CMS models were particularly close to MDD for three functional 316 
domains where the similarity scores between models and the disease are greater than 0.5 - 317 
“transport, localization & cellular import/export”, “development/differentiation & immune 318 
system” and “cellular response & receptor signalling.” 319 
4. Discussion  320 
Despite the high prevalence and considerable clinical impact of MDD, progress in 321 
understanding its pathophysiology has proved difficult, thought to be due to the 322 
heterogeneous and complex nature of the disorder (Krishnan and Nestler, 2008). Animal 323 
models of MDD have been utilised for the identification of novel drug targets and have 324 
provided new insights into the genetic and molecular alterations  which are thought to 325 
underpin the disorder (McArthur and Borsini, 2006). However, challenges have arisen in 326 
comparing alterations in animal models with the underlying molecular disease factors in 327 
MDD measured in serum (Chan et al., 2014) or brain tissue (Gottschalk et al., 2014). 328 
Therefore, most comparisons are based on behavioural phenotypes, sometimes additionally 329 
supplemented with histological and electrophysiological data. This has led to difficulties in 330 
bias and irreproducibility, as many of the behavioural characteristics for MDD cannot be 331 
translationally evaluated in animals (Krishnan and Nestler, 2011). 332 
Here, we present a novel systems biology approach allowing the comparison of brain changes 333 
from three rodent models with those observed in human MDD brains. Thus, we were able to 334 
assess which model reflects changes in MDD most closely for various pathophysiological 335 
features of the disease. The approach seeks to compare human and animal brain tissue on a 336 
functional level using GO terms annotated to proteins. Proteomic analysis has several 337 
advantages over genomic/transcriptomic analysis, as protein changes represent the 338 
transcribed and translated genetic information resulting from epigenetic and mRNA 339 
modifications more closely reflect the disease pathophysiology (Bayés and Grant, 2009). 340 
Twin studies, for example, have approximated the heritability of MDD at 37% suggesting 341 
that genetic investigations may not be the optimum basis for a comparison (Sullivan et al., 342 
2000). Similar to the case of schizophrenia and other psychiatric disorders, evidence suggests 343 
that MDD is a polygenic disorder with the disease phenotypes arising as a consequence of 344 
many small risk genes together with environmental factors (Lohoff, 2010).   345 
Through this approach, we were able to quantify seven functional domains identified as 346 
altered in MDD post-mortem brain tissue, which are all represented across two or more of the 347 
investigated animal models. We showed that the four functional domains “transport, 348 
localization & cellular import/export”, “cytoskeleton & DNA/RNA processes”, “intracellular 349 
sig./regulation & post-translational modification”, and “cellular response & receptor 350 
signalling”, are represented most closely by the SD model. Previous rodent studies of SD 351 
stress have found brain changes implying impaired cell proliferation mechanisms (Schmidt 352 
and Duman, 2007) which is consistent with our finding that the SD model is characterised 353 
especially through intracellular signalling and post-translational modification. In addition, we 354 
were able to demonstrate that the functional domains “development/differentiation & immune 355 
system” and “carbohydrate metabolism & cellular respiration” are represented most closely 356 
by the CMS model. It is unsurprising that immune dysfunction was represented strongly in 357 
this model as disturbed HPA function, dampened neurogenesis and increased oxidative stress 358 
have been reported in rat CMS models (Farooq et al., 2012; Van Bokhoven et al., 2011). The 359 
“development/differentiation & immune system” domain is also strongly represented in the 360 
SD model. This is in line with previous studies demonstrating that SD stress induces pro-361 
inflammatory signalling including increased monocyte trafficking via a variety of immune-362 
regulatory pathways found to be dysfunctional in the CNS of MDD patients (Christoffel et al. 363 
2011; Monje et al. 2011). It is interesting to note that the PNS model displayed low similarity 364 
scores for four of the five functional domains of MDD. The PNS model also yielded the 365 
fewest protein abundance changes between stressed and non-stressed states and we cannot 366 
exclude the possibility that this reflects the wide range of adaptations in rodents exposed to 367 
prenatal stress. Although most experiments show a clear effect of PNS on the phenotype, 368 
substantial variation can be observed across both pregnant dams and pups within a study 369 
(Boersma and Tamashiro, 2015). On the other hand animals analysed in the SD model were 370 
selected for susceptibility to social stress, potentially increasing intra group homogeneity.   371 
This study supports the notion that systemic commonalities exist between MDD brain tissue 372 
and rodent models of the disease. This is the first proteomic approach for a cross-species 373 
comparison which combines non-hypothesis driven label-free LC-MS
E 
profiling of matched 374 
post-mortem brain samples with a novel functional analysis procedure. There are multiple 375 
strengths of the methodology. At the protein annotation stage, a joint rodent database was 376 
used to avoid bias towards a particular species. Protein changes were identified using a 377 
statistical approach which accounted for the variance present in the data due to common 378 
confounders such as age, sex and substance abuse, while simultaneously avoiding over-379 
fitting. Preclinical studies typically explore the functional meaning of the changes seen in sets 380 
of individual proteins through pathway analyses, while this study sought to examine 381 
functional similarities between species through enrichment of protein-protein interaction 382 
networks. These networks account for the complex way in which proteins influence each 383 
other at multiple levels, and how their interactions underpin cellular processes on a systems 384 
level, which cannot be represented by pathway analysis alone, thus expanding the functional 385 
scope of the study. Directionality in terms of protein signalling is not accounted for in this 386 
study, but as yet, there is only limited annotation information available allowing to account 387 
for directionality in PPI networks in an unbiased manner.  388 
The method outlined in this paper is intended as a template which could be used for future 389 
studies comparing further animal models of MDD to the human disease, such as genetic 390 
mouse models. Despite taking steps to reduce a rodent species-specific bias through a joint 391 
protein database, we are aware that full comparability of preclinical models might only be 392 
achievable on a species specific level. As both mice and rats come with possible advantages 393 
to potential future experimental designs (tissue amount and sample size, available 394 
behavioural paradigms, ease of genetic manipulation) our results regarding the comparative 395 
validity have to be interpreted with caution. In addition, it should be noted that the applied 396 
proteome extraction protocol and the subsequent in silico analyses in both human post 397 
mortem brain and rodent tissue can only deliver an approximate view of the underlying 398 
proteomes as multiple cell types are used simultaneously and are therefore represented jointly 399 
in the significant abundance changes. Subsequent analyses should consider the fractionization 400 
of samples, rendering the analyses of targeted sub-proteomes possible, e.g. the extraction of 401 
integral membrane proteins. 402 
In summary, we have shown that different environmental stress models of MDD can 403 
represent individual functional aspects of the disease more closely than others. The 404 
development of a methodology which can quantify molecular similarity between preclinical 405 
models and MDD in this way is needed, as it is generally agreed that individual models are 406 
unlikely to mirror the full extent of the human disease (Czéh et al., 2016). Therefore, a 407 
combination of models, each mirroring different molecular changes found in the human 408 
pathophysiology may be the way forward in preclinical research. Theories that MDD could 409 
be a constellation of diseases, manifesting in behavioural symptoms which correlate with 410 
different neurobiological adaptations (Carboni, 2013), suggest that preclinical models 411 
targeting different symptom clusters are likely to be of increasing importance in the search 412 
for novel pharmacological compounds. There is a pressing need for pharmacological 413 
interventions that differ from current approaches which have largely focused on 414 
monoaminergic neurotransmission (Brigitta, 2002). Future research should aim to re-evaluate 415 
these disease-model comparisons incorporating proteomic analysis from genetic and 416 
pharmacological models. The ability to apply this novel method to conduct a direct functional 417 
comparison between multiple preclinical models and MDD will help gain greater insights 418 
into the underlying molecular and cellular mechanisms behind behavioural abnormalities and 419 
their response to pharmacological interventions, as we attempt to obtain a greater 420 
understanding of the consequences of environmental stressors in the context of affective 421 
disorders. 422 
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Figure Captions 433 
Figure 1. Identification of functional domains of human MDD represented across two or 434 
more rodent models. Vertical axes on the right side represent rodent functional groups. 435 
Hierarchical clustering using Ward’s criterion was used on both vertical and horizontal axes 436 
to identify related clusters of groups for both MDD and each model.  437 
(A Prenatal Stress 438 
(B) Chronic Mild Stress 439 
(C) Social Defeat 440 
Figure 2. Networks of GO terms representing the functional domains of MDD which were 441 
identified across at least two rodent models. Projection of significantly overlapping GO terms 442 
into functional networks enabled the identification of a vector of unique terms underlying a 443 
particular domain for both MDD and each rodent model. Representative GO terms for each 444 
domain are highlighted.  445 
(A ) MDD  (B)  Prenatal Stress  (C)  Chronic Mild Stress  (D) Social Defeat 446 
References 447 
Agid, O., Shapira, B., Zislin, J., Ritsner, M., Hanin, B., Murad, H., Troudart, T., Bloch, M., 448 
Heresco-Levy, U., Lerer, B., 1999. Environment and vulnerability to major psychiatric 449 
illness: a case control study of early parental loss in major depression, bipolar disorder 450 
and schizophrenia. Mol. Psychiatry 4, 163–72. 451 
Apweiler, R., Bairoch, A., Wu, C.H., Barker, W.C., Boeckmann, B., Ferro, S., Gasteiger, E., 452 
Huang, H., Lopez, R., Magrane, M., Martin, M.J., Natale, D.A., O’Donovan, C., 453 
Redaschi, N., Yeh, L.-S.L., 2004. UniProt: the Universal Protein knowledgebase. 454 
Nucleic Acids Res. 32, D115–D119. doi:10.1093/nar/gkh131 455 
Barkus, C., 2013. Genetic mouse models of depression. Curr. Top. Behav. Neurosci. 14, 55–456 
78. doi:10.1007/7854_2012_224 457 
Bayés, A., Grant, S.G.N., 2009. Neuroproteomics: understanding the molecular organization 458 
and complexity of the brain. Nat. Rev. Neurosci. 10, 635–646. doi:10.1038/nrn2701 459 
Beniger, J.R., Barnett, V., Lewis, T., 1980. Outliers in Statistical Data. Contemp. Sociol. 9, 460 
560. doi:10.2307/2066277 461 
Benjamini, Y., Hochberg, Y., 1995. Benjamini Y, Hochberg Y. Controlling the false 462 
discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 463 
57, 289–300. doi:10.2307/2346101 464 
Berton, O., Hahn, C.-G., Thase, M.E., 2012. Are we getting closer to valid translational 465 
models for major depression? Science 338, 75–9. doi:10.1126/science.1222940 466 
Berton, O., McClung, C. a, Dileone, R.J., Krishnan, V., Renthal, W., Russo, S.J., Graham, D., 467 
Tsankova, N.M., Bolanos, C. a, Rios, M., Monteggia, L.M., Self, D.W., Nestler, E.J., 468 
2006. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat 469 
stress. Science (80-. ). 311, 864–868. doi:10.1126/science.1120972 470 
Bindea, G., Mlecnik, B., Hackl, H., Charoentong, P., Tosolini, M., Kirilovsky, A., Fridman, 471 
W.-H., Pagès, F., Trajanoski, Z., Galon, J., 2009. ClueGO: a Cytoscape plug-in to 472 
decipher functionally grouped gene ontology and pathway annotation networks. 473 
Bioinformatics 25, 1091–1093. doi:10.1093/bioinformatics/btp101 474 
Boersma, G.J., Tamashiro, K.L., 2015. Individual differences in the effects of prenatal stress 475 
exposure in rodents. Neurobiol. Stress 1, 100–108. doi:10.1016/j.ynstr.2014.10.006 476 
Borsini, F., Meli, A., 1988. Is the forced swimming test a suitable model for revealing 477 
antidepressant activity? Psychopharmacology (Berl). 94, 147–60. 478 
Brigitta, B., 2002. Pathophysiology of depression and mechanisms of treatment. Dialogues 479 
Clin. Neurosci. 4, 7–20. 480 
Carboni, L., 2013. Peripheral biomarkers in animal models of major depressive disorder. Dis. 481 
Markers 35, 33–41. doi:10.1155/2013/284543 482 
Chan, M.K., Gottschalk, M.G., Haenisch, F., Tomasik, J., Ruland, T., Rahmoune, H., Guest, 483 
P.C., Bahn, S., 2014. Applications of blood-based protein biomarker strategies in the 484 
study of psychiatric disorders. Prog. Neurobiol. 122, 45–72. 485 
doi:10.1016/j.pneurobio.2014.08.002 486 
Charney, D.S., Manji, H.K., 2004. Life stress, genes, and depression: multiple pathways lead 487 
to increased risk and new opportunities for intervention. Sci. STKE 2004, re5. 488 
doi:10.1126/stke.2252004re5 489 
Christoffel, D.J., Golden, S.A., Dumitriu, D., Robison, A.J., Janssen, W.G., Ahn, H.F., 490 
Krishnan, V., Reyes, C.M., Han, M.-H., Ables, J.L., Eisch, A.J., Dietz, D.M., Ferguson, 491 
D., Neve, R.L., Greengard, P., Kim, Y., Morrison, J.H., Russo, S.J., 2011. IκB kinase 492 
regulates social defeat stress-induced synaptic and behavioral plasticity. J. Neurosci. 31, 493 
314–21. doi:10.1523/JNEUROSCI.4763-10.2011 494 
Cline, M.S., Smoot, M., Cerami, E., Kuchinsky, A., Landys, N., Workman, C., Christmas, R., 495 
Avila-Campilo, I., Creech, M., Gross, B., Hanspers, K., Isserlin, R., Kelley, R., 496 
Killcoyne, S., Lotia, S., Maere, S., Morris, J., Ono, K., Pavlovic, V., Pico, A.R., Vailaya, 497 
A., Wang, P.-L., Adler, A., Conklin, B.R., Hood, L., Kuiper, M., Sander, C., 498 
Schmulevich, I., Schwikowski, B., Warner, G.J., Ideker, T., Bader, G.D., 2007. 499 
Integration of biological networks and gene expression data using Cytoscape. Nat. 500 
Protoc. 2, 2366–2382. doi:10.1038/nprot.2007.324 501 
Cox, D.A., Gottschalk, M.G., Wesseling, H., Ernst, A., Cooper, J.D., Bahn, S., 2016. 502 
Proteomic systems evaluation of the molecular validity of preclinical psychosis models 503 
compared to schizophrenia brain pathology. Schizophr. Res. 504 
doi:10.1016/j.schres.2016.06.012 505 
Cryan, J.F., Holmes, A., 2005. The ascent of mouse: advances in modelling human 506 
depression and anxiety. Nat. Rev. Drug Discov. 4, 775–90. doi:10.1038/nrd1825 507 
Czéh, B., Fuchs, E., Wiborg, O., Simon, M., 2016. Animal models of major depression and 508 
their clinical implications. Prog. Neuropsychopharmacol. Biol. Psychiatry 64, 293–310. 509 
doi:10.1016/j.pnpbp.2015.04.004 510 
Ernst, A., Ma, D., Garcia-Perez, I., Tsang, T.M., Kluge, W., Schwarz, E., Guest, P.C., 511 
Holmes, E., Sarnyai, Z., Bahn, S., 2012. Molecular validation of the acute phencyclidine 512 
rat model for schizophrenia: identification of translational changes in energy metabolism 513 
and neurotransmission. J. Proteome Res. 11, 3704–14. doi:10.1021/pr300197d 514 
Farooq, R.K., Isingrini, E., Tanti, A., Le Guisquet, A.-M., Arlicot, N., Minier, F., Leman, S., 515 
Chalon, S., Belzung, C., Camus, V., 2012. Is unpredictable chronic mild stress (UCMS) 516 
a reliable model to study depression-induced neuroinflammation? Behav. Brain Res. 517 
231, 130–7. doi:10.1016/j.bbr.2012.03.020 518 
Fröhlich, H., Speer, N., Zell, A., 2006. Kernel Based Functional Gene Grouping, in: Proc. Int. 519 
Joint Conf. Neural Networks. pp. 6886–6891. 520 
Gottschalk, M.G., Wesseling, H., Guest, P.C., Bahn, S., 2014. Proteomic enrichment analysis 521 
of psychotic and affective disorders reveals common signatures in presynaptic 522 
glutamatergic signaling and energy metabolism. Int. J. Neuropsychopharmacol. 18, 523 
pyu019. doi:10.1093/ijnp/pyu019 524 
Hermjakob, H., Montecchi-Palazzi, L., Lewington, C., Mudali, S., Kerrien, S., Orchard, S., 525 
Vingron, M., Roechert, B., Roepstorff, P., Valencia, A., Margalit, H., Armstrong, J., 526 
Bairoch, A., Cesareni, G., Sherman, D., Apweiler, R., 2004. IntAct: an open source 527 
molecular interaction database. Nucleic Acids Res. 32, D452-5. doi:10.1093/nar/gkh052 528 
Herrera-Ruiz, M., García-Beltrán, Y., Mora, S., Díaz-Véliz, G., Viana, G.S.B., Tortoriello, J., 529 
Ramírez, G., 2006. Antidepressant and anxiolytic effects of hydroalcoholic extract from 530 
Salvia elegans. J. Ethnopharmacol. 107, 53–8. doi:10.1016/j.jep.2006.02.003 531 
Huang, D.W., Sherman, B.T., Tan, Q., 2007. The DAVID Gene Functional Classification 532 
Tool: a novel biological module-centric algorithm to functionally analyze large gene 533 
lists. Genome Biol. 8, R183. doi:10.1186/gb-2007-8-9-r183 534 
Krishnan, V., Han, M.-H., Graham, D.L., Berton, O., Renthal, W., Russo, S.J., Laplant, Q., 535 
Graham, A., Lutter, M., Lagace, D.C., Ghose, S., Reister, R., Tannous, P., Green, T.A., 536 
Neve, R.L., Chakravarty, S., Kumar, A., Eisch, A.J., Self, D.W., Lee, F.S., Tamminga, 537 
C.A., Cooper, D.C., Gershenfeld, H.K., Nestler, E.J., 2007. Molecular adaptations 538 
underlying susceptibility and resistance to social defeat in brain reward regions. Cell 539 
131, 391–404. doi:10.1016/j.cell.2007.09.018 540 
Krishnan, V., Nestler, E.J., 2011. Animal models of depression: molecular perspectives. Curr. 541 
Top. Behav. Neurosci. 7, 121–47. doi:10.1007/7854_2010_108 542 
Krishnan, V., Nestler, E.J., 2008. The molecular neurobiology of depression. Nature 455, 543 
894–902. doi:10.1038/nature07455 544 
Lerman, G., Shakhnovich, B.E., 2007. Defining functional distance using manifold 545 
embeddings of gene ontology annotations. Proc. Natl. Acad. Sci. U. S. A. 104, 11334–546 
11339. doi:10.1073/pnas.0702965104 547 
Li, L., Ching, W., Chan, Y., Mamitsuka, H., 2010. On network-based kernel methods for 548 
protein-protein interactions with applications in protein functions prediction. J. Syst. Sci. 549 
Complex. 23, 917–930. doi:10.1007/s11424-010-0207-y 550 
Lohoff, F.W., 2010. Overview of the genetics of major depressive disorder. Curr. Psychiatry 551 
Rep. 12, 539–46. doi:10.1007/s11920-010-0150-6 552 
Ma, D., Chan, M.K., Lockstone, H.E., Pietsch, S.R., Jones, D.N.C., Cilia, J., Hill, M.D., 553 
Robbins, M.J., Benzel, I.M., Umrania, Y., Guest, P.C., Levin, Y., Maycox, P.R., Bahn, 554 
S., 2009. Antipsychotic treatment alters protein expression associated with presynaptic 555 
function and nervous system development in rat frontal cortex. J. Proteome Res. 8, 556 
3284–97. doi:10.1021/pr800983p 557 
Markou, A., Chiamulera, C., Geyer, M.A., Tricklebank, M., Steckler, T., 2009. Removing 558 
obstacles in neuroscience drug discovery: the future path for animal models. 559 
Neuropsychopharmacology 34, 74–89. doi:10.1038/npp.2008.173 560 
Martins-de-Souza, D., Martins, D., Menezes de Oliveira, B., dos Santos Farias, A., Horiuchi, 561 
R.S.O., Crepaldi Domingues, C., de Paula, E., Marangoni, S., Gattaz, W.F., Dias-Neto, 562 
E., Camillo Novello, J., 2007. The use of ASB-14 in combination with CHAPS is the 563 
best for solubilization of human brain proteins for two-dimensional gel electrophoresis. 564 
Brief. Funct. Genomic. Proteomic. 6, 70–5. doi:10.1093/bfgp/elm009 565 
McArthur, R., Borsini, F., 2006. Animal models of depression in drug discovery: a historical 566 
perspective. Pharmacol. Biochem. Behav. 84, 436–52. doi:10.1016/j.pbb.2006.06.005 567 
Merico, D., Isserlin, R., Stueker, O., Emili, A., Bader, G.D., 2010. Enrichment map: a 568 
network-based method for gene-set enrichment visualization and interpretation. PLoS 569 
One 5, e13984. doi:10.1371/journal.pone.0013984 570 
Monje, F.J., Cabatic, M., Divisch, I., Kim, E.-J., Herkner, K.R., Binder, B.R., Pollak, D.D., 571 
2011. Constant darkness induces IL-6-dependent depression-like behavior through the 572 
NF-κB signaling pathway. J. Neurosci. 31, 9075–83. doi:10.1523/JNEUROSCI.1537-573 
11.2011 574 
Moreau, J.L., Jenck, F., Martin, J.R., Mortas, P., Haefely, W.E., 1992. Antidepressant 575 
treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by 576 
ventral tegmentum self-stimulation behavior in rats. Eur. Neuropsychopharmacol. 2, 43–577 
49. doi:10.1016/0924-977X(92)90035-7 578 
Nestler, E.J., Hyman, S.E., 2010. Animal models of neuropsychiatric disorders. Nat. 579 
Neurosci. 13, 1161–9. doi:10.1038/nn.2647 580 
Pollak, D.D., Rey, C.E., Monje, F.J., 2010. Rodent models in depression research: classical 581 
strategies and new directions. Ann. Med. 42, 252–64. doi:10.3109/07853891003769957 582 
Pothion, S., Bizot, J.-C., Trovero, F., Belzung, C., 2004. Strain differences in sucrose 583 
preference and in the consequences of unpredictable chronic mild stress. Behav. Brain 584 
Res. 155, 135–46. doi:10.1016/j.bbr.2004.04.008 585 
R Development Core Team, 2013. R: A language and environment for statistical computing. 586 
R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-587 
project.org/. R Found. Stat. Comput. Vienna, Austria. 588 
Roweis, S.T., Saul, L.K., 2000. Nonlinear dimensionality reduction by locally linear 589 
embedding. Science 290, 2323–6. doi:10.1126/science.290.5500.2323 590 
Schmidt, H.D., Duman, R.S., 2007. The role of neurotrophic factors in adult hippocampal 591 
neurogenesis, antidepressant treatments and animal models of depressive-like behavior. 592 
Behav. Pharmacol. 18, 391–418. doi:10.1097/FBP.0b013e3282ee2aa8 593 
Sickmann, H.M., Arentzen, T.S., Dyrby, T.B., Plath, N., Kristensen, M.P., 2015. Prenatal 594 
stress produces sex-specific changes in depression-like behavior in rats: implications for 595 
increased vulnerability in females. J. Dev. Orig. Health Dis. 6, 462–74. 596 
doi:10.1017/S2040174415001282 597 
Speer, N., Frohlich, H., Spieth, C., Zell, A., 2005. Functional grouping of genes using 598 
spectral clustering and Gene Ontology, in: Neural Networks, 2005. IJCNN ’05. 599 
Proceedings. 2005 IEEE International Joint Conference on. pp. 298–303. 600 
doi:10.1109/IJCNN.2005.1555846 601 
Sullivan, P.F., Neale, M.C., Kendler, K.S., 2000. Genetic epidemiology of major depression: 602 
review and meta-analysis. Am. J. Psychiatry 157, 1552–62. 603 
doi:10.1176/appi.ajp.157.10.1552 604 
Torrey, E.F., Webster, M., Knable, M., Johnston, N., Yolken, R.H., 2000. The Stanley 605 
Foundation brain collection and Neuropathology Consortium. Schizophr. Res. 44, 151–606 
155. doi:10.1016/S0920-9964(99)00192-9 607 
Trivedi, M.H., Rush, A.J., Wisniewski, S.R., Nierenberg, A.A., Warden, D., Ritz, L., 608 
Norquist, G., Howland, R.H., Lebowitz, B., McGrath, P.J., Shores-Wilson, K., Biggs, 609 
M.M., Balasubramani, G.K., Fava, M., 2006. Evaluation of outcomes with citalopram 610 
for depression using measurement-based care in STAR*D: implications for clinical 611 
practice. Am. J. Psychiatry 163, 28–40. doi:10.1176/appi.ajp.163.1.28 612 
Van Bokhoven, P., Oomen, C.A., Hoogendijk, W.J.G., Smit, A.B., Lucassen, P.J., Spijker, S., 613 
2011. Reduction in hippocampal neurogenesis after social defeat is long-lasting and 614 
responsive to late antidepressant treatment. Eur. J. Neurosci. 33, 1833–40. 615 
doi:10.1111/j.1460-9568.2011.07668.x 616 
Willner, P., Towell,  a., Sampson, D., Sophokleous, S., Muscat, R., 1987. Reduction of 617 
sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic 618 
antidepressant. Psychopharmacology (Berl). 93, 358–364. doi:10.1007/BF00187257 619 
Wohleb, E.S., Powell, N.D., Godbout, J.P., Sheridan, J.F., 2013. Stress-induced recruitment 620 
of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J. 621 
Neurosci. 33, 13820–33. doi:10.1523/JNEUROSCI.1671-13.2013 622 
Yang, C.R., Zhang, Z.G., Bai, Y.Y., Zhou, H.F., Zhou, L., Ruan, C.S., Li, F., Li, C.Q., 623 
Zheng, H.Y., Shen, L.J., Zhou, X.F., 2014. Foraging activity is reduced in a mouse 624 
model of depression. Neurotox. Res. 25, 235–47. doi:10.1007/s12640-013-9411-6 625 
Zanzoni, A., Montecchi-Palazzi, L., Quondam, M., Ausiello, G., Helmer-Citterich, M., 626 
Cesareni, G., 2002. MINT: a Molecular INTeraction database. FEBS Lett. 513, 135–627 
140. doi:10.1016/S0014-5793(01)03293-8 628 
Zare, H., Kaveh, M., Khodursky, A., 2011. Inferring a Transcriptional Regulatory Network 629 
from Gene Expression Data Using Nonlinear Manifold Embedding. PLoS One 6, 630 
e21969. doi:10.1371/journal.pone.0021969 631 
 632 
 633 
